{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:54:50Z","timestamp":1792616090172,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012580","name":"Natural Science Foundation of Tianjin Science and Technology Correspondent Project","doi-asserted-by":"publisher","award":["24JCQNJC00460"],"award-info":[{"award-number":["24JCQNJC00460"]}],"id":[{"id":"10.13039\/501100012580","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jinf.2026.106858","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:18:05Z","timestamp":1789661885000},"page":"106858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Global epidemiology, clinical burden, and antimicrobial resistance of the WHO priority pathogens: An updated review focusing on understudied non-baumannii Acinetobacter and emerging extensively drug-resistant threats"],"prefix":"10.1016","volume":"93","author":[{"given":"Shulei","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanying","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naixin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiliang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jinf.2026.106858_bib1","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S1473-3099(25)00118-5","article-title":"The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance","volume":"25","author":"Sati","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2026.106858_bib2","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41579-024-01054-w","article-title":"ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics","volume":"22","author":"Miller","year":"2024","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"10.1016\/j.jinf.2026.106858_bib3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/cid\/ciad556","article-title":"Clinical outcomes and bacterial characteristics of carbapenem-resistant Acinetobacter baumannii among patients from different global regions","volume":"78","author":"Wang","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2026.106858_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/17843286.2025.2546420","article-title":"Emerging threat of WHO priority pathogens in ICU-associated CLABSI and CAUTI: an integrated analysis of resistance patterns, epidemiological trends, and stewardship strategies","volume":"80","author":"Anand","year":"2025","journal-title":"Acta Clin Belg"},{"issue":"2","key":"10.1016\/j.jinf.2026.106858_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11274-026-04797-1","article-title":"The rise of WHO-priority pathogens in central line associated bloodstream infection: challenging the AWaRe paradigm in critical care","volume":"42","author":"Anand","year":"2026","journal-title":"World J Microbiol Biotechnol"},{"issue":"1","key":"10.1016\/j.jinf.2026.106858_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/jambio\/lxac023","article-title":"Triple combination of SPR741, clarithromycin, and erythromycin against Acinetobacter baumannii and its tolerant phenotype","volume":"134","author":"Li","year":"2023","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.jinf.2026.106858_bib7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jgar.2021.02.033","article-title":"Prevalence and molecular epidemiology of carbapenem-resistant Gram-negative bacilli and their resistance determinants in the Eastern Mediterranean Region over the last decade","volume":"25","author":"Sleiman","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"issue":"3","key":"10.1016\/j.jinf.2026.106858_bib8","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10123-023-00321-9","article-title":"Development of diagnostic tests for pathogen identification and detection of antimicrobial resistance on WHO global priority pathogens using modular real-time nucleic acid amplification test","volume":"26","author":"Bang","year":"2023","journal-title":"Int Microbiol"},{"key":"10.1016\/j.jinf.2026.106858_bib9","article-title":"Comprehensive analysis of antimicrobial resistance in the Southwest Indian Ocean: focus on WHO critical and high priority pathogens","volume":"12","author":"Hoarau","year":"2024","journal-title":"Front Public Health"},{"issue":"1","key":"10.1016\/j.jinf.2026.106858_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens14010046","article-title":"Comparative analysis of clinical characteristics and antimicrobial resistance between Acinetobacter baumannii and other acinetobacter species","volume":"14","author":"Kim","year":"2025","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.jinf.2026.106858_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12879-023-08945-y","article-title":"First report of Acinetobacter pittii acute community-acquired pneumonia in an immunocompetent patient in France following a heat wave","volume":"24","author":"Souhail","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2026.106858_bib12","first-page":"112","article-title":"Antibacterial effect of carbon nanotube containing chemical compounds on drug-resistant isolates of Acinetobacter baumannii","volume":"13","author":"Banihashemi","year":"2021","journal-title":"Iran J Microbiol"},{"issue":"6","key":"10.1016\/j.jinf.2026.106858_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01981-23","article-title":"Trends in the susceptibility of U.S. Acinetobacter baumannii-calcoaceticus species complex and Stenotrophomonas maltophilia isolates to minocycline, 2014-2021","volume":"11","author":"Pfaller","year":"2023","journal-title":"Microbiol Spectr"},{"issue":"1","key":"10.1016\/j.jinf.2026.106858_bib14","doi-asserted-by":"crossref","DOI":"10.1099\/acmi.0.001100.v3","article-title":"WHO priority pathogens, ESKAPE bacteria, and antimicrobial resistance surveillance in household wastewater, Gombe, Nigeria","volume":"8","author":"Muhammad","year":"2026","journal-title":"Access Microbiol"},{"key":"10.1016\/j.jinf.2026.106858_bib15","article-title":"Using implementation science to bridge the gaps between political commitment and action in antimicrobial resistance governance under the one health approach in the WHO Southeast Asia and Western Pacific regions","volume":"66","author":"Yu","year":"2026","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"10.1016\/j.jinf.2026.106858_bib16","article-title":"Healthcare-associated infections in critically Ill COVID-19 patients across evolving pandemic waves: a retrospective ICU study","volume":"62","author":"Altintepe Baskurt","year":"2026","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"10.1016\/j.jinf.2026.106858_bib17","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1038\/s41598-021-84293-8","article-title":"A descriptive analysis of antimicrobial resistance patterns of WHO priority pathogens isolated in children from a tertiary care hospital in India","volume":"11","author":"Mogasale","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jinf.2026.106858_bib18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12866-025-03783-1","article-title":"Antimicrobial resistance patterns of WHO priority pathogens at general hospital in Southern Ethiopia during the COVID-19 pandemic, with particular reference to ESKAPE-group isolates of surgical site infections","volume":"25","author":"Seid","year":"2025","journal-title":"BMC Microbiol"},{"issue":"3","key":"10.1016\/j.jinf.2026.106858_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248614","article-title":"Drug resistance phenotypes and genotypes in Mexico in representative gram-negative species: results from the infivar network","volume":"16","author":"Garza-Gonz\u00e1lez","year":"2021","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.jinf.2026.106858_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411438","article-title":"Multi-drug resistance in bacterial genomes-a comprehensive bioinformatic analysis","volume":"24","author":"Domingues","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.jinf.2026.106858_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2025.102692","article-title":"Molecular epidemiology of carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in human infections around the Red Sea","volume":"18","author":"Ragueh","year":"2025","journal-title":"J Infect Public Health"},{"issue":"8","key":"10.1016\/j.jinf.2026.106858_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0329539","article-title":"Healthcare utilization associated with antimicrobial resistance at a tertiary hospital in Vietnam: a retrospective observational study from 2016 to 2021","volume":"20","author":"Nguyen","year":"2025","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jinf.2026.106858_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10482-025-02181-x","article-title":"Impact of COVID-19 on the prevalence of multi-drug-resistant bacteria: a literature review and meta-analysis","volume":"118","author":"Ahmed","year":"2025","journal-title":"Antonie Van Leeuwenhoek"},{"issue":"1","key":"10.1016\/j.jinf.2026.106858_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100104","article-title":"Synergistic combinations of antimicrobial peptides and conventional antibiotics: a strategy to delay resistance emergence in World Health Organization priority bacteria","volume":"78","author":"Roque-Borda","year":"2026","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.jinf.2026.106858_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/14787210.2024.2440018","article-title":"Unraveling sulbactam-durlobactam: insights into its role in combating infections caused by Acinetobacter baumannii","volume":"23","author":"Fu","year":"2025","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"10.1016\/j.jinf.2026.106858_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13568-025-01837-1","article-title":"Recent insights on phage therapy against multidrug-resistant Acinetobacter baumannii","volume":"15","author":"Elshamy","year":"2025","journal-title":"AMB Express"},{"issue":"2","key":"10.1016\/j.jinf.2026.106858_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/epidemiologia6020021","article-title":"The global burden of multidrug-resistant bacteria","volume":"6","author":"Marino","year":"2025","journal-title":"Epidemiologia (Basel)"},{"issue":"8","key":"10.1016\/j.jinf.2026.106858_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238195","article-title":"Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones","volume":"15","author":"Mohammed","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jinf.2026.106858_bib29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.18683\/germs.2022.1308","article-title":"Febrile illness of bacterial etiology in a public fever hospital in Egypt: high burden of multidrug resistance and WHO priority gram negative pathogens","volume":"12","author":"Mostafa","year":"2022","journal-title":"Germs"},{"issue":"11","key":"10.1016\/j.jinf.2026.106858_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens13111006","article-title":"Antimicrobial resistance profile of zoonotic clinically relevant WHO priority pathogens","volume":"13","author":"Meade","year":"2024","journal-title":"Pathogens"},{"key":"10.1016\/j.jinf.2026.106858_bib31","article-title":"New antifungal strategies and drug development against WHO critical priority fungal pathogens","volume":"15","author":"Li","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"10.1016\/j.jinf.2026.106858_bib32","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S2666-5247(24)00042-9","article-title":"The WHO fungal priority pathogens list: a crucial reappraisal to review the prioritisation","volume":"5","author":"Casalini","year":"2024","journal-title":"Lancet Microbe"},{"issue":"4","key":"10.1016\/j.jinf.2026.106858_bib33","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1080\/21501203.2025.2561612","article-title":"Research advances and public health strategies in China on WHO priority fungal pathogens","volume":"16","author":"Wang","year":"2025","journal-title":"Mycology"},{"issue":"6","key":"10.1016\/j.jinf.2026.106858_bib34","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.cmi.2024.03.006","article-title":"New treatment options for critically important WHO fungal priority pathogens","volume":"31","author":"Kriegl","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2026.106858_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.soh.2025.100145","article-title":"The 2024 WHO bacterial priority pathogens list: a critical evolution from a global One Health perspective","volume":"5","author":"Mukhopadhyay","year":"2026","journal-title":"Sci One Health"},{"issue":"28","key":"10.1016\/j.jinf.2026.106858_bib36","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.28.2400231","article-title":"Pathogen prioritisation for wastewater surveillance ahead of the Paris 2024 Olympic and Paralympic Games, France","volume":"29","author":"Toro","year":"2024","journal-title":"Eur Surveill"},{"issue":"8","key":"10.1016\/j.jinf.2026.106858_bib37","doi-asserted-by":"crossref","first-page":"9357","DOI":"10.1021\/acsomega.3c08676","article-title":"Accelerating antimicrobial peptide discovery for WHO priority pathogens through predictive and interpretable machine learning models","volume":"9","author":"Tsai","year":"2024","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.jinf.2026.106858_bib38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40121-020-00395-2","article-title":"Continuous evolution: perspective on the epidemiology of carbapenemase resistance among enterobacterales and other gram-negative bacteria","volume":"10","author":"Hansen","year":"2021","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.jinf.2026.106858_bib39","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jgar.2024.03.020","article-title":"Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018-2022","volume":"37","author":"Wise","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"issue":"7","key":"10.1016\/j.jinf.2026.106858_bib40","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1093\/jac\/dkae140","article-title":"Global epidemiology and antimicrobial resistance of Enterobacterales harbouring genes encoding OXA-48-like carbapenemases: insights from the results of the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme 2018-2021","volume":"79","author":"Lee","year":"2024","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jinf.2026.106858_bib41","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1093\/cid\/ciad220","article-title":"High-level colonization with antibiotic-resistant enterobacterales among individuals in a semi-urban setting in South India: an antibiotic resistance in communities and hospitals (ARCH) study","volume":"77","author":"Kumar","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2026.106858_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0341636","article-title":"Extended-spectrum \u03b2-lactamase and carbapenemase-producing Enterobacterales among adult patients and their family members at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia","volume":"21","author":"Abera","year":"2026","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jinf.2026.106858_bib43","article-title":"Epidemiology of ESBL-producing, carbapenem-resistant, and carbapenemase-producing enterobacterales in Southern Africa","volume":"15","author":"Ntshonga","year":"2026","journal-title":"Antibiot (Basel)"},{"issue":"1","key":"10.1016\/j.jinf.2026.106858_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-04460-z","article-title":"Phenotypic characterisation and prevalence of carbapenem-resistant Enterobacterales in a tertiary care centre in Bihar India","volume":"15","author":"DebBarma","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jinf.2026.106858_bib45","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.2147\/IDR.S328521","article-title":"Antibiotic resistance genes among carbapenem-resistant enterobacterales (CRE) isolates of Prapokklao Hospital, Chanthaburi Province, Thailand","volume":"14","author":"Tunyong","year":"2021","journal-title":"Infect Drug Resist"},{"issue":"1","key":"10.1016\/j.jinf.2026.106858_bib46","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1186\/s12879-024-09726-x","article-title":"Phenotypic and molecular characterization of multidrug-resistant Enterobacterales isolated from clinical samples in Palestine: a focus on extended-spectrum \u03b2-lactamase- and carbapenemase-producing isolates","volume":"24","author":"Ibaideya","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2026.106858_bib47","first-page":"839","article-title":"Molecular characterization & risk factors associated with carbapenemase-producing enterobacterales acquisition in hospitalised patients in a tertiary care setting","volume":"162","author":"Sunil Bawankar","year":"2025","journal-title":"Indian J Med Res"},{"issue":"6","key":"10.1016\/j.jinf.2026.106858_bib48","article-title":"Dissemination of OXA-48- and NDM-1-Producing Enterobacterales Isolates in an Algerian Hospital","volume":"11","author":"Abderrahim","year":"2022","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"10.1016\/j.jinf.2026.106858_bib49","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12879-024-09145-y","article-title":"Trends of antimicrobial susceptibilities and multidrug-resistant colonization rate in patients transferred from long-term care facilities during 2017-2022: a cross-sectional study","volume":"24","author":"Park","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2026.106858_bib50","article-title":"Insights into the rising threat of carbapenem-resistant enterobacterales and Pseudomonas aeruginosa epidemic infections in Eastern Europe: a systematic literature review","volume":"13","author":"Piotrowski","year":"2024","journal-title":"Antibiotics (Basel)"},{"issue":"6","key":"10.1016\/j.jinf.2026.106858_bib51","doi-asserted-by":"crossref","first-page":"639","DOI":"10.37201\/req\/096.2021","article-title":"Clinical management of cUTI, cIAI, and HABP\/VABP attributable to carbapenem-resistant Gram-negative infections in Spain","volume":"34","author":"Ferrer","year":"2021","journal-title":"Rev Esp Quimioter"},{"issue":"5","key":"10.1016\/j.jinf.2026.106858_bib52","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/02676591211005697","article-title":"Incremental effect of complications on mortality and hospital costs in adult ECMO patients","volume":"37","author":"Dhamija","year":"2022","journal-title":"Perfusion"},{"key":"10.1016\/j.jinf.2026.106858_bib53","doi-asserted-by":"crossref","DOI":"10.1590\/1980-220x-reeusp-2025-0060en","article-title":"Clinical aspects and short-term prognosis in a cohort of patients with infective endocarditis, S\u00e3o Paulo, Brazil","volume":"59","author":"Becker","year":"2025","journal-title":"Rev Esc Enferm USP"},{"issue":"5","key":"10.1016\/j.jinf.2026.106858_bib54","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ihj.2021.07.004","article-title":"Impact of concomitant respiratory infections in the management and outcomes acute myocardial infarction-cardiogenic shock","volume":"73","author":"Patlolla","year":"2021","journal-title":"Indian Heart J"},{"issue":"2","key":"10.1016\/j.jinf.2026.106858_bib55","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jopan.2024.04.004","article-title":"Postoperative outcomes in surgical coronavirus disease 2019 patients: a retrospective cohort study","volume":"40","author":"Hegde","year":"2025","journal-title":"J Perianesth Nurs"},{"issue":"9","key":"10.1016\/j.jinf.2026.106858_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0286815","article-title":"Quantifying association and disparities between diabetes complications and COVID-19 outcomes: a retrospective study using electronic health records","volume":"18","author":"Paramita","year":"2023","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jinf.2026.106858_bib57","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jceh.2021.01.005","article-title":"The clinical impact of cirrhosis on the hospital outcomes of patients admitted with influenza infection: propensity score matched analysis of 2011-2017 US hospital data","volume":"11","author":"Lee","year":"2021","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jinf.2026.106858_bib58","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jor.2025.06.031","article-title":"Hospital-acquired COVID-19 and its effect on length of stay and mortality in orthopedic admissions: a matched cohort study","volume":"66","author":"Ron","year":"2025","journal-title":"J Orthop"},{"issue":"1","key":"10.1016\/j.jinf.2026.106858_bib59","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s10120-025-01686-8","article-title":"Impact of prophylactic drain placement on intra-abdominal infections after gastrectomy: nationwide inpatient database study in Japan","volume":"29","author":"Kouzu","year":"2026","journal-title":"Gastric Cancer"},{"issue":"1","key":"10.1016\/j.jinf.2026.106858_bib60","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1097\/SLA.0000000000003835","article-title":"Impact of complications after pancreatoduodenectomy on mortality, organ failure, hospital stay, and readmission: analysis of a nationwide audit","volume":"275","author":"Smits","year":"2022","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.jinf.2026.106858_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12040650","article-title":"Implementing a personalized antimicrobial stewardship program for women with gynecological cancers and healthcare-associated infections","volume":"12","author":"Di Giambenedetto","year":"2022","journal-title":"J Pers Med"},{"issue":"1","key":"10.1016\/j.jinf.2026.106858_bib62","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/s12864-024-10410-2","article-title":"Potential involvement of beta-lactamase homologous proteins in resistance to beta-lactam antibiotics in gram-negative bacteria of the ESKAPEE group","volume":"25","author":"de Souza","year":"2024","journal-title":"BMC Genom"},{"key":"10.1016\/j.jinf.2026.106858_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1048633","article-title":"Last resort beta-lactam antibiotics for treatment of New-Delhi Metallo-Beta-Lactamase producing enterobacterales and other difficult-to-treat resistance in gram-negative bacteria: a real-life study","volume":"12","author":"Larcher","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"10.1016\/j.jinf.2026.106858_bib64","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02418-24","article-title":"Effects of different mechanisms on antimicrobial resistance in Pseudomonas aeruginosa: a strategic system for evaluating antibiotics against gram-negative bacteria","volume":"13","author":"Tsai","year":"2025","journal-title":"Microbiol Spectr"},{"issue":"3","key":"10.1016\/j.jinf.2026.106858_bib65","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02145-21","article-title":"Cefotaxime exposure selects mutations within the CA-domain of envZ which promote antibiotic resistance but repress biofilm formation in Salmonella","volume":"10","author":"Trampari","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"6","key":"10.1016\/j.jinf.2026.106858_bib66","article-title":"RND efflux pump induction: a crucial network unveiling adaptive antibiotic resistance mechanisms of gram-negative bacteria","volume":"13","author":"Novelli","year":"2024","journal-title":"Antibiotics (Basel)"},{"issue":"11","key":"10.1016\/j.jinf.2026.106858_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2024.102544","article-title":"The influence of efflux pump, outer membrane permeability and \u03b2-lactamase production on the resistance profile of multi, extensively and pandrug resistant Klebsiella pneumoniae","volume":"17","author":"Hussein","year":"2024","journal-title":"J Infect Public Health"},{"issue":"6","key":"10.1016\/j.jinf.2026.106858_bib68","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00552-20","article-title":"Impact of intrinsic resistance mechanisms on potency of QPX7728, a new ultrabroad-spectrum beta-lactamase inhibitor of serine and metallo-beta-lactamases in enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii","volume":"64","author":"Lomovskaya","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.jinf.2026.106858_bib69","doi-asserted-by":"crossref","first-page":"16","DOI":"10.37201\/req\/s02.02.2022","article-title":"Mechanism of action of cefiderocol","author":"Soriano","year":"2022","journal-title":"Rev Esp Quimioter"},{"issue":"36","key":"10.1016\/j.jinf.2026.106858_bib70","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.2174\/0113816128303422240723091231","article-title":"An update on colistin in clinical healthcare unit in the Kingdom of Saudi Arabia: a narrative review","volume":"30","author":"Faidah","year":"2024","journal-title":"Curr Pharm Des"},{"issue":"6","key":"10.1016\/j.jinf.2026.106858_bib71","article-title":"Investigation of plasmid-mediated colistin resistance genes (mcr-1-8) in enterobacterales isolates","volume":"16","author":"G\u00fcrb\u00fcz","year":"2024","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/j.jinf.2026.106858_bib72","article-title":"Phosphoethanolamine transferases as drug discovery targets for therapeutic treatment of multi-drug resistant pathogenic gram-negative bacteria","volume":"12","author":"Thai","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"11","key":"10.1016\/j.jinf.2026.106858_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12112532","article-title":"Cefiderocol in combating carbapenem-resistant Acinetobacter baumannii: action and resistance","volume":"12","author":"Yousefi","year":"2024","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.jinf.2026.106858_bib74","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s00203-025-04298-z","article-title":"Newly developed antibiotics against multidrug-resistant and carbapenem-resistant Gram-negative bacteria: action and resistance mechanisms","volume":"207","author":"Ba\u015faran","year":"2025","journal-title":"Arch Microbiol"},{"issue":"2","key":"10.1016\/j.jinf.2026.106858_bib75","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1021\/acsinfecdis.2c00417","article-title":"Re-sensitization of multidrug-resistant and colistin-resistant gram-negative bacteria to colistin by povarov\/doebner-derived compounds","volume":"9","author":"Onyedibe","year":"2023","journal-title":"ACS Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2026.106858_bib76","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02068-20","article-title":"Mechanistic understanding enables the rational design of salicylanilide combination therapies for gram-negative infections","volume":"11","author":"Copp","year":"2020","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.jinf.2026.106858_bib77","article-title":"Bacteriophage treatment induces phenotype switching and alters antibiotic resistance of ESBL Escherichia coli","volume":"14","author":"R\u00f3zsa","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jinf.2026.106858_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.586433","article-title":"Bacteriocins to thwart bacterial resistance in gram negative bacteria","volume":"11","author":"Telhig","year":"2020","journal-title":"Front Microbiol"},{"issue":"6","key":"10.1016\/j.jinf.2026.106858_bib79","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/QCO.0000000000000784","article-title":"New evidence for managing gram-negative bloodstream infections","volume":"34","author":"Nutman","year":"2021","journal-title":"Curr Opin Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2026.106858_bib80","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3947\/ic.2024.0055","article-title":"Optimizing treatment for carbapenem-resistant Acinetobacter baumannii complex infections: a review of current evidence","volume":"56","author":"Choi","year":"2024","journal-title":"Infect Chemother"},{"key":"10.1016\/j.jinf.2026.106858_bib81","first-page":"1","article-title":"Nephrotoxicity risks of colistin-combination therapy: a USFDA adverse event reporting system analysis using disproportionality and interaction assessment","volume":"2","author":"Sridharan","year":"2025","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"10.1016\/j.jinf.2026.106858_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107410","article-title":"Individualized antimicrobial therapy using antibiotic combination testing and therapeutic drug monitoring to treat carbapenem-resistant Acintobacter baumannii infection","volume":"65","author":"Chua","year":"2025","journal-title":"Int J Antimicrob Agents"},{"issue":"13","key":"10.1016\/j.jinf.2026.106858_bib83","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202423799","article-title":"Machine learning-assisted prediction of photothermal metal-phenolic networks","volume":"64","author":"Fan","year":"2025","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"10.1016\/j.jinf.2026.106858_bib84","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-023-01134-9","article-title":"Antibiotic stewardship in the ICU: time to shift into overdrive","volume":"13","author":"Mokrani","year":"2023","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.1016\/j.jinf.2026.106858_bib85","first-page":"453","article-title":"Best practices: appropriate use of the new \u03b2-lactam\/\u03b2-lactamase inhibitor combinations, ceftazidime-avibactam and ceftolozane-tazobactam in South Africa","volume":"37","author":"Brink","year":"2022","journal-title":"S Afr J Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2026.106858_bib86","article-title":"Use of novel antibiograms to determine the need for earlier susceptibility testing and administration for new \u03b2-Lactam\/\u03b2-Lactamase inhibitors in the United States","volume":"11","author":"Klinker","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jinf.2026.106858_bib87","article-title":"Procalcitonin-guided antibiotic therapy in elderly ICU patients with severe pneumonia: a retrospective analysis of biomarker dynamics","volume":"12","author":"Liu","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jinf.2026.106858_bib88","article-title":"Guidance on C-reactive protein point-of-care testing and complementary strategies to improve antibiotic prescribing for adults with lower respiratory tract infections in primary care","volume":"10","author":"Van Hecke","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10.1016\/j.jinf.2026.106858_bib89","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.002007","article-title":"Targeted \u2018knock out\u2019 therapy with a combination antimicrobial regimen restores treatment options in the management of extensively drug-resistant carbapenemase-producing organisms","volume":"74","author":"Ali","year":"2025","journal-title":"J Med Microbiol"},{"issue":"15","key":"10.1016\/j.jinf.2026.106858_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30153072","article-title":"Potential use of cefiderocol and nanosilver in wound dressings to control multidrug-resistant gram-negative bacteria","volume":"30","author":"Binert-Kusztal","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.jinf.2026.106858_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1385261","article-title":"Endolysins: a new antimicrobial agent against antimicrobial resistance. Strategies and opportunities in overcoming the challenges of endolysins against Gram-negative bacteria","volume":"15","author":"Khan","year":"2024","journal-title":"Front Pharmacol"},{"issue":"14","key":"10.1016\/j.jinf.2026.106858_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/nano12142469","article-title":"Photothermal regulated nanozyme of CuFeS2 nanoparticles for efficiently promoting wound healing infected by multidrug resistant bacteria","volume":"12","author":"Liu","year":"2022","journal-title":"Nanomaterials (Basel)"},{"issue":"23","key":"10.1016\/j.jinf.2026.106858_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262311267","article-title":"Photodynamic inactivation enhances antibiotic efficacy without affecting drug stability: insights into photosensitizer-antibiotic combination therapies","volume":"26","author":"Acosta","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.jinf.2026.106858_bib94","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02836-22","article-title":"Acinetobacter nosocomialis causes as severe disease as Acinetobacter baumannii in Northeast Thailand: underestimated role of A. nosocomialis in Infection","volume":"10","author":"Nithichanon","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jinf.2026.106858_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2025.105820","article-title":"Genomic insights of two Acinetobacter non-baumannii strains with uncommon mechanisms of resistance leading to cefiderocol resistance","volume":"135","author":"Akhtar","year":"2025","journal-title":"Infect Genet Evol"},{"issue":"6","key":"10.1016\/j.jinf.2026.106858_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.syapm.2024.126560","article-title":"Proposal of Acinetobacter thermotolerans sp. nov. to accommodate bovine feces-dwelling bacteria growing at 47 \u00b0C","volume":"47","author":"Shestivska","year":"2024","journal-title":"Syst Appl Microbiol"},{"key":"10.1016\/j.jinf.2026.106858_bib97","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jgar.2024.09.005","article-title":"Coexistence of seven different carbapenemase producers in a single hospital admission screening confirmed by whole-genome sequencing","volume":"39","author":"Fuchs","year":"2024","journal-title":"J Glob Antimicrob Resist"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445326001842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445326001842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:26:15Z","timestamp":1792614375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445326001842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":97,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0163445326001842"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2026.106858","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global epidemiology, clinical burden, and antimicrobial resistance of the WHO priority pathogens: An updated review focusing on understudied non-baumannii Acinetobacter and emerging extensively drug-resistant threats","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2026.106858","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106858"}}